BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 9134831)

  • 1. [A coagulation of fibrinolytic study in children with nephrotic syndrome: evaluation of hypercoagulability by measuring with plasmin- alpha 2 plasmin inhibitor complex and FDP D-dimer].
    Oikawa T; Muramatsu Y; Akashi S; Usui N
    Nihon Jinzo Gakkai Shi; 1997 Mar; 39(2):144-9. PubMed ID: 9134831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Measurements of plasmin-alpha 2 plasmin inhibitor complex and FDP.D dimer levels in the fibrinolytic therapy of acute pulmonary thromboembolism].
    Yamasawa F; Hasegawa N; Asano K; Sayama K; Fujita H; Urano T; Aoki T; Ishizaka A; Kanazawa M; Kawashiro T
    Kokyu To Junkan; 1992 Jul; 40(7):685-90. PubMed ID: 1387724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Coagulation and fibrinolysis parameters in disseminated intravascular coagulation (DIC)].
    Nakagawa T; Saito H; Watanabe Y; Sato M; Murakawa E
    Rinsho Byori; 1991 Mar; 39(3):309-14. PubMed ID: 1828842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Concentration of thrombin antithrombin III complex and plasmin alpha 2-plasmin inhibitor complex in nephrotic syndrome].
    Kobayashi M; Katayama T; Ochiai S; Yoshida M; Kaito K; Masuoka H; Shimada T; Nishiwaki K; Sakai O
    Nihon Jinzo Gakkai Shi; 1991 Jul; 33(7):653-8. PubMed ID: 1836241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Coagulation-fibrinolytic abnormality and symptomatic vasospasm in the acute stage of ruptured cerebral aneurysms--analysis of alpha 2 PI, alpha 2 PIC, FDP and D.dimer].
    Shibahashi H; Yamaura A
    No To Shinkei; 1991 Mar; 43(3):239-46. PubMed ID: 1830749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical usefulness of the measurements of plasmin-alpha 2-plasmin inhibitor complex and plasma tissue factor activity in patients with disseminated intravascular coagulation].
    Fukuda C; Iijima K; Nakamura K
    Rinsho Byori; 1996 Aug; 44(8):750-6. PubMed ID: 8816061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome.
    Vaziri ND; Gonzales EC; Shayestehfar B; Barton CH
    J Lab Clin Med; 1994 Jul; 124(1):118-24. PubMed ID: 7518491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on coagulation fibrinolytic systems in predialysis patients with chronic renal failure--comparison between patients with chronic glomerulonephritis and patients with diabetic nephropathy].
    Nagake Y; Makino H; Yorioka N; Nomura S; Osawa G; Yamakido M; Kawasaki H; Kato Y; Matsuzaki M; Shikata K; Uemasu J; Somiya H; Fujii Z; Hayashida S; Nasu T; Oyabu Y; Nitta Y; Kawanishi H; Usui K; Fujiwara K; Takasugi N; Kanehara K; Hamaguchi N; Kumagai I; Ota Z
    Nihon Jinzo Gakkai Shi; 1997 Jul; 39(5):474-82. PubMed ID: 9283213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular markers of hemostatic-mechanisms--plasmin-alpha 2 plasmin inhibitor complex].
    Kawai Y; Watanabe K
    Rinsho Byori; 1989 Mar; 37(3):248-55. PubMed ID: 2526263
    [No Abstract]   [Full Text] [Related]  

  • 10. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
    Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
    Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Coagulation and fibrinolysis in pregnancy].
    Yuasa S; Ishizawa M; Yuki Y; Minoura T; Fujita N; Takahashi H; Yoshimura M; Yamamoto T; Okada H
    Rinsho Byori; 1992 Dec; 40(12):1287-91. PubMed ID: 1284915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coagulation and fibrinolysis factors in dialysis patients with and without ischemic heart disease.
    Oda H; Ohno M; Ohashi H
    Adv Perit Dial; 2000; 16():152-5. PubMed ID: 11045282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Progress in diagnosis of disseminated intravascular coagulation (DIC)--diagnostic criteria of DIC].
    Koyama T; Aoki N
    Nihon Rinsho; 1993 Jan; 51(1):43-9. PubMed ID: 8433527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical application of laboratory diagnosis: leukemia and DIC].
    Deguchi K; Zhao LJ; Shirakawa S
    Rinsho Byori; 1991 Jul; 39(7):736-42. PubMed ID: 1833571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Advancement in the diagnosis of disseminated intravascular coagulation for the surgeon].
    Ohsato K; Okamoto K
    Nihon Rinsho; 1993 Jan; 51(1):50-5. PubMed ID: 8381885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies on molecular markers for hemostasis and thrombosis in various renal diseases].
    Shibata T; Ishii T; Tomo T; Kaneko K; Nasu M; Magari Y; Fukushima K
    Nihon Jinzo Gakkai Shi; 1991 Apr; 33(4):373-8. PubMed ID: 1831516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of factors of coagulation and fibrinolysis in progression of lung cancer].
    Nagayama M; Tachibana A; Hayakawa H; Sato A
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Feb; 31(2):180-5. PubMed ID: 8390588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Urinary-plasmin alpha 2 plasmin inhibitor complex (PIC) in patients with diabetic nephropathy].
    Saigo K; Ryo R; Yamaguchi N
    Rinsho Byori; 1993 Jul; 41(7):785-8. PubMed ID: 8361049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid-related hemostatic abnormalities in the elderly: imbalance between coagulation and fibrinolysis.
    Kario K; Matsuo T
    Atherosclerosis; 1993 Nov; 103(2):131-8. PubMed ID: 8292090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serial changes in hemostatic molecular markers after urokinase therapy of acute myocardial infarction].
    Goto S; Kawai Y; Watanabe K; Hori S; Abe S; Handa S; Ikeda Y
    Kokyu To Junkan; 1992 Jan; 40(1):89-95. PubMed ID: 1532665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.